(Total Views: 367)
Posted On: 09/21/2017 10:25:06 PM
Post# of 30067
I think you mean $1.8B, not $1.8M.
Ok, I did look at the stock history. The market valued RGIN at $183M at its peak and it quickly (very quickly) took an immediate dive from there like all OTC biotechs do.
The $1.8B was only in the outlandish lawsuit.
So, I'm confused at what you are looking at.
And do your research. The only reason that it was at $183M was because AJ Discala at the Broadsmoore Group took it public via a reverse merger. He is Meadow Soprano's former flame and a notorious pump and dump artist. I think he might be in jail after the FBI moved in on him.
I only deal with facts and the $1.8B number is complete crap.
And I'm long.
Ok, I did look at the stock history. The market valued RGIN at $183M at its peak and it quickly (very quickly) took an immediate dive from there like all OTC biotechs do.
The $1.8B was only in the outlandish lawsuit.
So, I'm confused at what you are looking at.
And do your research. The only reason that it was at $183M was because AJ Discala at the Broadsmoore Group took it public via a reverse merger. He is Meadow Soprano's former flame and a notorious pump and dump artist. I think he might be in jail after the FBI moved in on him.
I only deal with facts and the $1.8B number is complete crap.
And I'm long.
Quote:
It was the stock market that valued it at $1.8M. Not me, not the courts, not an outlandish lawsuit. That is reality and the facts. Look at the stock history.
(1)
(0)
